Treponema Pallidum (Recombinant  TP P15-P17-P47 fusion Protein  (His Tag)) antibody and antigen (Recombinant protein)

 Download 

Product information

Catalog No.	Description	US $ Price (per mg)
GMP-IVD-P008-Tg001-Ag01	Recombinant human Treponema Pallidum (TP) Recombinant  TP P15-P17-P47 fusion Protein  (His Tag) Protein	3090
GMP-IVD-P008-Tg001-Ab01	Anti-human Treponema Pallidum (TP) Recombinant  TP P15-P17-P47 fusion Protein  (His Tag) mouse monoclonal antibody (mAb)	1953
GMP-IVD-P008-Tg001-Ab02	Anti-human Treponema Pallidum (TP) Recombinant  TP P15-P17-P47 fusion Protein  (His Tag) mouse monoclonal antibody (mAb)	1953
GMP-IVD-P008-Tg001-Ab03	Anti-human Treponema Pallidum (TP) Recombinant  TP P15-P17-P47 fusion Protein  (His Tag) human monoclonal antibody (mAb)	1953
GMP-IVD-P008-Tg001-Ab04	Anti-human Treponema Pallidum (TP) Recombinant  TP P15-P17-P47 fusion Protein  (His Tag) human monoclonal antibody (mAb)	1953

Size： 1mg | 10mg | 100mg

Product Description

Cat No. of Products	GMP-IVD-P008-Tg001-Ag01
Product Name	Recombinant human Treponema Pallidum (TP) Recombinant  TP P15-P17-P47 fusion Protein  (His Tag) Protein
Pathogen	Treponema Pallidum
Target/Biomarker	Recombinant  TP P15-P17-P47 fusion Protein  (His Tag)
Expression platform	E.coli
Isotypes	Recombinant Antigen
Bioactivity validation	Recombinant  TP P15-P17-P47 fusion Protein  (His Tag) (Recombinant  TP P15-P17-P47 fusion Protein  (His Tag)) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Recombinant  TP P15-P17-P47 fusion Protein  (His Tag) level test of Infectious disease (syphilis) and related syndrome evaluation.
Tag	His
Products description	Recombinant human Treponema Pallidum (TP) Recombinant  TP P15-P17-P47 fusion Protein  (His Tag) Protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-IVD-P008-Tg001-Ab01, GMP-IVD-P008-Tg001-Ab02
Product Name	Anti-human Treponema Pallidum (TP) Recombinant  TP P15-P17-P47 fusion Protein  (His Tag) mouse monoclonal antibody (mAb)
Pathogen	Treponema Pallidum
Target/Biomarker	Recombinant  TP P15-P17-P47 fusion Protein  (His Tag)
Expression platform	CHO
Isotypes	Mouse IgG
Bioactivity validation	Recombinant  TP P15-P17-P47 fusion Protein  (His Tag) (Recombinant  TP P15-P17-P47 fusion Protein  (His Tag)) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Recombinant  TP P15-P17-P47 fusion Protein  (His Tag) level test of Infectious disease (syphilis) and related syndrome evaluation.
Tag	mFc
Products description	Anti-human Treponema Pallidum (TP) Recombinant  TP P15-P17-P47 fusion Protein  (His Tag) mouse monoclonal antibody (mAb) was expressed in CHO - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-IVD-P008-Tg001-Ab03, GMP-IVD-P008-Tg001-Ab04
Product Name	Anti-human Treponema Pallidum (TP) Recombinant  TP P15-P17-P47 fusion Protein  (His Tag) human monoclonal antibody (mAb)
Pathogen	Treponema Pallidum
Target/Biomarker	Recombinant  TP P15-P17-P47 fusion Protein  (His Tag)
Expression platform	CHO
Isotypes	Human lgG1
Bioactivity validation	Recombinant  TP P15-P17-P47 fusion Protein  (His Tag) (Recombinant  TP P15-P17-P47 fusion Protein  (His Tag)) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Recombinant  TP P15-P17-P47 fusion Protein  (His Tag) level test of Infectious disease (syphilis) and related syndrome evaluation.
Tag	hFc
Products description	Anti-human Treponema Pallidum (TP) Recombinant  TP P15-P17-P47 fusion Protein  (His Tag) human monoclonal antibody (mAb) was expressed in CHO - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

Click to get more Data / Case study about the product.

Target/Biomarker information

syphilis, systemic disease that is caused by the spirochete bacterium Treponema pallidum. Syphilis is usually a sexually transmitted disease, but it is occasionally acquired by direct nonsexual contact with an infected person, and it can also be acquired by an unborn fetus through infection in the mother. A related group of infections, collectively known as treponematosis or nonvenereal syphilis, is not spread by sexual contact and is localized in warm parts of the world where crowded conditions and poor health care favor its development.

About GDU